Source:
Ali FS. Next generation anti-VEGFs: Is real world data consistent with the clinical trials? Presented at: OSN New York and OSN New York Retina; Nov. 8-10, 2024; New York.
Disclosures:
Ali reports consulting for 4DMT, AbbVie/Allergan, Apellis, Astellas, EyePoint, Genentech, Ocuphire, OcuTerra, Optomed and Regeneron and being on the speakers’ bureau for Apellis and Astellas.
Leave a Reply